+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Do randomized clinical trial selection criteria reflect levels of risk as observed in a general population of acute myocardial infarction survivors? The PEGASUS trial in the light of the FAST-MI 2005 registry



Do randomized clinical trial selection criteria reflect levels of risk as observed in a general population of acute myocardial infarction survivors? The PEGASUS trial in the light of the FAST-MI 2005 registry



International Journal of Cardiology 223: 604-610



Few clinical trials have focused on populations with a history of distant myocardial infarction (MI). The PEGASUS trial assessed the impact of dual antiplatelet therapy in such patients, selected by enrichment criteria of high cardiovascular risk. Whether the PEGASUS population reflects the risk of a broader post-MI population is questionable. We analyzed whether 4-year mortality of a routine-practice population would differ according to the inclusion and exclusion criteria used in PEGASUS. FAST-MI is a nationwide French registry recruiting acute MI patients in November 2005; 2490 patients alive and without recurrent MI at one year were classified into three groups: Group 1 ("PEGASUS-like" population; n=1395; 56%), Group 2 (population having ≥1 exclusion criterion for the trial; n=677; 27%), and group 3 (population meeting neither the PEGASUS inclusion nor exclusion criteria; n=418, 17%). Group 1 patients were older than Group 3 patients, with higher GRACE scores, more comorbidity, and less STEMI, but were younger than the PEGASUS trial population. Enrichment criteria successfully defined a population at higher risk: 4-year survival 83% in Group 1, 97% in Group 2, and 68% in Group 3 (P<0.001). Among risk-enrichment criteria, age alone was highly discriminant: in PEGASUS-like patients, survival was 78% in those ≥65 versus 94% in those <65years. Enrichment criteria used in PEGAGUS succeed in defining a population at increased risk in patients with prior MI, age being the most discriminant factor. The trial population, however, was notably younger and more masculine than the corresponding real-life population in France. Clinicaltrials.govnumber:NCT00673036.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057648251

Download citation: RISBibTeXText

PMID: 27561167

DOI: 10.1016/j.ijcard.2016.08.191


Related references

Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial). American Heart Journal 175: 36-46, 2016

Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial. American Heart Journal 189: 94, 2017

Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: A randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction. Journal of Nuclear Cardiology 11(4): 458-469, 2004

Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale. American Heart Journal 160(6): 1042-1048, 2010

Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry. Critical Care 18(5): 516, 2014

Long-term prognostic impact of body mass index and waist circumference in hospital survivors of acute myocardial infarction. Data from the French FAST-MI 2005 registry. European Heart Journal 34(Suppl 1): 1948-1948, 2013

Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). International Journal of Cancer 120(4): 868-874, 2007

A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: The Serial Markers, Acute Myocardial Infarction and Rapid Treatment Trial (SMARTT). Journal of the American College of Cardiology 36(5): 1500-1506, 2000

Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial. Circulation 108(16 Suppl 1): Iii14-Iii21, 2003

General anesthesia during percutaneous transluminary coronary angioplasty for acute myocardial infarction: results of a randomized controlled clinical trial. Anesthesia and Analgesia 68(3): 201-207, 1989

Increased mortality risk in diabetic patients discharged from hospital with insulin therapy after an acute myocardial infarction: Data from the FAST-MI 2005 registry. European Heart Journal. Acute Cardiovascular Care 8(3): 218-230, 2019

A prospective randomized trial of intracoronary t-PA versus coronary angioplasty in acute myocardial infarction Japanese Intervention Trial in Myocardial Infarction. Circulation 96(8 Suppl. ): I536, 10/21/97, 1997

Prevalence, clinical profile and 3-year survival of acute myocardial infarction patients with and without obstructive coronary lesions: the FAST-MI 2005 registry. International Journal of Cardiology 172(1): E247-E249, 2014

Prevalence, clinical profile and 3-year outcomes of acute myocardial infarction patients with and without obstructive coronary lesions: the FAST-MI 2005 registry. European Heart Journal 34(Suppl 1): P4299-P4299, 2013

Time for a prospective, randomized trial of the "open artery hypothesis" in survivors of acute myocardial infarction. American Journal of Cardiology 69(16): 1359-1360, 1992